HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The study on the treatment of Xuebijing injection (XBJ) in adults with severe or critical Corona Virus Disease 2019 and the inhibitory effect of XBJ against SARS-CoV-2.

AuthorsQinhai Ma, Minshan Qiu, Hongxia Zhou, Jie Chen, Xue Yang, Zhenxuan Deng, Liping Chen, Jinchao Zhou, Yuping Liao, Qimin Chen, Qianwei Zheng, Lihua Cai, Lihan Shen, Zifeng Yang
JournalPharmacological research (Pharmacol Res) Vol. 160 Pg. 105073 (10 2020) ISSN: 1096-1186 [Electronic] Netherlands
PMID32653650 (Publication Type: Letter, Research Support, Non-U.S. Gov't)
Chemical References
  • Antiviral Agents
  • Cytokines
  • Drugs, Chinese Herbal
  • Xuebijing
Topics
  • Acute Lung Injury (drug therapy, etiology)
  • Antiviral Agents (adverse effects, pharmacology, therapeutic use)
  • Betacoronavirus (drug effects)
  • COVID-19
  • Coronavirus Infections (complications, drug therapy)
  • Critical Care
  • Cytokines (metabolism)
  • Drugs, Chinese Herbal (adverse effects, pharmacology, therapeutic use)
  • Humans
  • Pandemics
  • Pneumonia, Viral (complications, drug therapy)
  • SARS-CoV-2

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: